$2.68T
Total marketcap
$45.67B
Total volume
BTC 49.87%     ETH 17.09%
Dominance

Synairgen SYGGF Stock

0.08 USD {{ price }} 27.239265% {{change_pct}}%
Market Cap
21.89M USD
LOW - HIGH [24H]
0.08 - 0.08 USD
VOLUME [24H]
1K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.06 USD

Synairgen Price Chart

Synairgen SYGGF Financial and Trading Overview

Synairgen stock price 0.08 USD
Previous Close 0.12 USD
Open 0.12 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.12 - 0.12 USD
52 Week Range 0.07 - 0.47 USD
Volume 3K USD
Avg. Volume 903 USD
Market Cap 24.37M USD
Beta (5Y Monthly) -2.208045
PE Ratio (TTM) N/A
EPS (TTM) -0.06 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

SYGGF Valuation Measures

Enterprise Value 4.69M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.1981683
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.232

Trading Information

Synairgen Stock Price History

Beta (5Y Monthly) -2.208045
52-Week Change -64.41%
S&P500 52-Week Change 20.43%
52 Week High 0.47 USD
52 Week Low 0.07 USD
50-Day Moving Average 0.13 USD
200-Day Moving Average 0.17 USD

SYGGF Share Statistics

Avg. Volume (3 month) 903 USD
Avg. Daily Volume (10-Days) 1.11K USD
Shares Outstanding 201.38M
Float 139.22M
Short Ratio N/A
% Held by Insiders 3.34%
% Held by Institutions 30.16%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -37.22%
Return on Equity (ttm) -61.61%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -20198000 USD
Net Income Avi to Common (ttm) -17645000 USD
Diluted EPS (ttm) -0.11
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 19.68M USD
Total Cash Per Share (mrq) 0.1 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 7.191
Book Value Per Share (mrq) 0.101

Cash Flow Statement

Operating Cash Flow (ttm) -14286000 USD
Levered Free Cash Flow (ttm) -9194500 USD

Profile of Synairgen

Country United States
State N/A
City Southampton
Address Mailpoint 810
ZIP SO16 6YD
Phone 44 23 8051 2800
Website https://www.synairgen.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 30

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Q&A For Synairgen Stock

What is a current SYGGF stock price?

Synairgen SYGGF stock price today per share is 0.08 USD.

How to purchase Synairgen stock?

You can buy SYGGF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Synairgen?

The stock symbol or ticker of Synairgen is SYGGF.

Which industry does the Synairgen company belong to?

The Synairgen industry is Biotechnology.

How many shares does Synairgen have in circulation?

The max supply of Synairgen shares is 263.72M.

What is Synairgen Price to Earnings Ratio (PE Ratio)?

Synairgen PE Ratio is now.

What was Synairgen earnings per share over the trailing 12 months (TTM)?

Synairgen EPS is -0.06 USD over the trailing 12 months.

Which sector does the Synairgen company belong to?

The Synairgen sector is Healthcare.